Anesthesiology, Pain Medicine · Dickinson, TX
NPI
1053433938
Since 2007
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3750 Medical Park Drive, Suite 200
Dickinson, TX, 77539
Phone (281) 534-1133
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
1,670 services
Medicare patients, 2024
147
Average age 69
Drug cost, 2024
$303K
9,272 prescriptions
Company payments, 2025
$159
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rehan Memon was code 99213 (office e&m - established), 484 times for 117 patients. In total Rehan Memon billed 1,670 services in 43 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 484 | 117 | $64.14 | $31K |
| 80307 Drug Tests | Office | 302 | 124 | $60.90 | $18K |
| 99214 Office E&M - Established | Office | 262 | 107 | $92.47 | $24K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 173 | 105 | $153.46 | $27K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 73 | 60 | $241.98 | $18K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 59 | 52 | $194.77 | $11K |
| 62323 Nerve Block Injection - Back | Office | 32 | 25 | $200.29 | $6,409 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 29 | 17 | $183.95 | $5,334 |
| 64493 Nerve Block Injection - Back | Office | 28 | 14 | $148.59 | $4,161 |
| 64494 Nerve Block Injection - Back | Office | 27 | 14 | $76.78 | $2,073 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 27 | 17 | $334.35 | $9,027 |
| 99204 Office E&M - New | Office | 19 | 19 | $118.68 | $2,255 |
| 20610 Joint Injection | Office | 19 | 15 | $51.08 | $970 |
By year: 2022 $177K for 2,055 services; 2023 $170K for 1,888 services; 2024 $181K for 1,670 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 302 | 124 | $60.90 | $18K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 173 | 105 | $153.46 | $27K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 73 | 60 | $241.98 | $18K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 59 | 52 | $194.77 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Rehan Memon prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,640 prescriptions and refills. In total Rehan Memon wrote 9,272 Medicare prescriptions that cost $303K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,640 | 3,644 | 437 | $89K |
| Gabapentin Generic | 842 | 847 | 155 | $7,444 |
| Cyclobenzaprine Hcl Generic | 812 | 819 | 169 | $7,363 |
| Tizanidine Hcl Generic | 584 | 584 | 103 | $4,430 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 377 | 377 | 89 | $7,336 |
| Pregabalin Generic | 375 | 375 | 69 | $8,492 |
| Lidocaine Generic | 359 | 375 | 92 | $38K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 272 | 272 | 35 | $5,871 |
| Meloxicam Generic | 270 | 270 | 63 | $498 |
| Diclofenac Sodium Generic | 252 | 260 | 107 | $7,241 |
| Tramadol Hcl Generic | 244 | 244 | 54 | $1,838 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 159 | 167 | 55 | $2,883 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 156 | 156 | 21 | $21K |
| Baclofen Generic | 151 | 151 | 34 | $1,517 |
| Methocarbamol Generic | 148 | 148 | 43 | $1,699 |
Brand drugs: 212 claims; generic drugs: 9,060 claims; opioid claims: 4,618.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rehan Memon $159 ($159 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $70.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.